Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Shares | 100.050 | 100.050 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 17.635 | 19.914 |
Price to Book | 3.631 | 3.681 |
Price to Sales | 2.176 | 2.446 |
Price to Cash Flow | 12.654 | 13.602 |
Dividend Yield | 1.783 | 1.598 |
5 Years Earnings Growth | 11.115 | 11.662 |
Name | Net % | Category Average |
---|---|---|
Technology | 31.040 | 28.001 |
Healthcare | 13.550 | 13.502 |
Financial Services | 12.000 | 14.052 |
Consumer Cyclical | 11.870 | 10.597 |
Communication Services | 8.730 | 8.586 |
Industrials | 6.440 | 8.939 |
Consumer Defensive | 6.340 | 5.954 |
Energy | 4.130 | 4.225 |
Real Estate | 2.300 | 2.382 |
Basic Materials | 2.100 | 3.006 |
Utilities | 1.500 | 2.454 |
Number of long holdings: 318
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Microsoft | US5949181045 | 9.51 | 423.85 | -0.16% | |
Apple | US0378331005 | 9.49 | 196.89 | +1.24% | |
Amazon.com | US0231351067 | 4.57 | 184.30 | -0.38% | |
NVIDIA | US67066G1040 | 3.86 | 1,208.61 | -0.11% | |
Alphabet A | US02079K3059 | 2.80 | 174.45 | -1.29% | |
Alphabet C | US02079K1079 | 2.41 | 175.95 | -1.35% | |
Tesla | US88160R1014 | 2.07 | 177.48 | -0.26% | |
UnitedHealth | US91324P1021 | 1.86 | 490.69 | -2.24% | |
Eli Lilly | US5324571083 | 1.71 | 849.99 | +1.52% | |
JPMorgan | US46625H1005 | 1.51 | 199.95 | +1.54% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
IE00BMTD2G30 | 954.62M | 16.28 | 16.56 | - | ||
IE00BMTD2Q38 | 139.57M | 9.46 | -2.28 | - | ||
IE00BMTD2L82 | 202.75M | 10.52 | - | - | ||
IE00BNNLSK63 | 469.38M | 37.98 | - | - |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review